$HTSC The Company holds a 15% equity stake in KRTL Biotech. KRTL Biotech has MFDS approval to study psilocybin in South Korea with its highly ambitious team of doctors, chemists and researchers to help cure debilitating diseases.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.